Objective: We compared the management of patients with symptomatic, unruptured abdominal aortic aneurysms (AAAs) treated at a tertiary care center between two decades. This 20-year period encapsulated a shift in surgical approach to aortic aneurysms from primarily open to primarily endovascular, and we sought to determine the effect of this shift in the evaluation, treatment, and clinical outcomes of patients with symptomatic AAA.
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METHODS
After obtaining Institutional Review Board approval, we searched our integrated institutional database to identify all patients who underwent open or endovascular repair for asymptomatic and symptomatic nonruptured AAA between January 1, 1995, and December 31, 2014. Patient informed consent was not obtained because of the retrospective nature of this record review. We used is a prospectively maintained (updated weekly) database that contains clinic data, including patient demographics, International Classification of Diseases, Ninth Revisioncoded diagnoses, Current Procedural Terminologycoded (American Medical Association, Chicago, Ill) procedures, clinical documents, surgical pathology reports, radiology reports and laboratory test results. 10 The search for our cohort was generated using International Classification of Diseases, Ninth Revision treatment and diagnosis codes for open or endovascular repair of nonruptured AAAs.
Patients were defined as symptomatic if they presented with the following symptoms attributed to their aneurysm: back pain, abdominal pain, flank pain, epigastric pain, hip pain, tenderness over aneurysm, sensation of abdominal fullness, or thromboembolism to the lower extremity. We excluded those with symptoms >60 days because it was possible that the AAA was not the cause of the symptoms. Other exclusion criteria included thoracoabdominal aneurysms, aortic dissections, and those with missing or incomplete medical records.
Data collected included demographics, comorbidities, and intraoperative details. Perioperative outcomes collected included mortality (defined as 30-day or in-hospital mortality), length of stay, and postoperative complications.
Postoperative complications were defined as complications that occurred during the postoperative hospital stay or #30 days of surgery. These included myocardial infarction, stroke, pulmonary complications, genitourinary complications, acute kidney injury, gastrointestinal complications, deep vein thrombosis, and wound infections. Acute kidney injury was defined using RIFLE (Risk, Injury, Failure, Loss, End-stage renal disease) criteria and included patients with an increase in creatinine postprocedure by two or more times from baseline or the new onset of dialysis.
11 Pulmonary complications were defined as pneumonia, acute respiratory distress syndrome, respiratory failure, or requirement of prolonged ventilation support or tracheostomy. Genitourinary complications were defined as ureteral injury, urinary tract infection, or urinary incontinence. Gastrointestinal complications included bowel ischemia or infarction, pancreatitis, or severe diarrhea, nausea, or vomiting. Long-term mortality was determined by record review and by cross-reference to the Social Security database, with death information up to date until March 31, 2016. Data were analyzed by comparing two eras, era 1 (January 1, 1995 
RESULTS
We identified 188 patients with symptomatic AAAs during the study interval. In era 1, 139 of the 1226 patients (11.3%) reviewed were excluded because of missing operative reports. As a result the lack of this information, we were unable to know whether they fit into our inclusion criteria and were symptomatic or asymptomatic. No patients were excluded in era 2. Of the 188 patients, 28 had documented symptoms for >60 days and were excluded, leaving a study cohort of 164 patients. Of these, 75 were treated in era 1 and 85 in era 2. The proportion of intact AAA repair patients who were symptomatic was similar in both eras (10% in era 1 and 11% in era 2).
Patient demographics between era 1 and era 2 were similar with regard to age, sex, race, smoking history, coronary artery disease, congestive heart failure, hypertension, chronic obstructive pulmonary disease, and diabetes mellitus (Table I) . Patients in era 2 had higher documented rates of hyperlipidemia (61.0% vs 31.1%; P ¼ .0002) and significantly higher rates of normal baseline renal function (82% vs 64%; P ¼ .008).
The most common presenting symptom for both eras was abdominal pain or back pain (Table II) . AAA presenting with embolization was equally uncommon in both eras (9.3% era 1 vs 8.2% era 2; P ¼ .8). Documentation of tender aneurysms was more common in era 1 than in era 2 (21.3% vs 4.7%; P ¼ .002). Aneurysm diameter, location, time to surgery, and proportion of inflammatory aneurysms were similar for both eras. A greater proportion of patients from era 2 received endovascular repair compared to era 1 (70.6% vs 32.0%; P < .0001). Intraoperative characteristics are summarized in Table III . For open procedures, there was no difference in graft diameters between eras. Open aneurysm repairs performed in era 2 were more likely to require suprarenal clamping (22% vs 44%; P ¼ .0485) and were associated with a trend toward greater intraoperative blood loss (2188 mL vs 1121 mL; P ¼ .08) compared with era 1. Patients who underwent endovascular repair in era 2 had less intraoperative blood loss (280 mL vs 661 mL; a Continuous data are presented as mean 6 standard deviation or median (interquartile range) and discrete data as number (%). P ¼ .02) and contrast volume use (102 mL vs 140 mL; P ¼ .009) compared with era 1. Stent graft size and fluoroscopic time were similar between eras. Two patients in era 2 underwent procedures outside of the instructions for use, including one patient who received a fenestrated device and a renal snorkel and a second patient who had a renal snorkel. Both patients survived the perioperative period and did not require dialysis; however, acute kidney injury did develop in the patient with a fenestration and snorkel.
Postoperative myocardial infarctions, pulmonary complications, genitourinary complications, and limb complications were similar between eras (Table IV) . Acute kidney injury was not significantly different over time, occurring in 13 of 75 (17%) in era 1 and in 10 of 85 (12%) in era 2 (P ¼ .3). In addition, an analysis by operative type showed there was also no significant difference in acute kidney injury rates. For open repairs, acute kidney injury developed in 12 of 51 patients (24%) vs three of 25 (12%) in era 2 (P ¼ .2). For endovascular AAA repair (EVAR) patients in era 1, acute kidney injury developed in only one of 24 (4%) vs seven of 60 (12%) in era 2, but this was not statistically significant (P ¼ .3). Gastrointestinal complications (primarily ischemic), however, were more common in era 1 (8.0% vs 0%; P ¼ .01), as were wound infections (5.3% vs 0%; P ¼ .047) ( Table IV) . The median length of stay was significantly shorter in era 2 than in era 1 (4.0 days vs 6.0 days; P ¼ .005). When stratified by operative type, there were no significant differences in lengths of stay between eras for open procedures (7.0 vs 7.0 days; P ¼ .63) or endovascular procedures (3.0 vs 3.0 days; P ¼ .81). The overall perioperative mortality rate was similar between eras (5.3% vs 5.9%; P > .99). There were no significant differences in perioperative mortality between eras compared by open (7.8% vs 8.0%; P > .99) and endovascular (0% vs 5.0%; P ¼ .6) operative approach. Long-term survival by era is depicted by the unadjusted KaplanMeier curve plotted in Approaching this analysis from a timing to repair standpoint (Tables V and VI) , we found that overall early mortality was 8.6% in patients undergoing same-day surgery and 2.5% with surgery delayed at least 1 day (P ¼ .09). The overall percentage of patients undergoing same-day surgery in era 1 vs era 2 was similar (48% vs 52%; P ¼ .8). Same-day surgery was more likely for open repairs patients in era 2 (76% vs 41%; P ¼ .004) and for EVAR patients in era 1 (67% vs 42%; P ¼ .04). The median length of stay was 6 days for same-day surgery and 5 days for surgery delayed at least 1 day (P ¼ .2), and no differences were found in lengths of stay when stratified by repair type. The rate of acute kidney injury was 16.1% with same-day surgery and 12.7% with surgery delayed as least 1 day (P ¼ .5), and no differences were found when stratified by repair type.
DISCUSSION
Our study represents the largest nondatabase analysis of outcomes of patients with symptomatic AAAs and is the first to examine the management and outcome of symptomatic AAAs over a period of 20 years, encapsulating a shift from an era of primarily open repair to primarily endovascular repair. Despite this dramatic change in surgical approach, we found the proportion of aneurysm repairs that were symptomatic and the majority of clinical outcomes were remarkably similar between eras.
Perioperative mortality in our study was lower than prior studies 2, 4, 6, 7, 12 compared with the primarily open era (7.9%) and similar to other studies 8,9,13,14 when looking at the primarily endovascular era (3.6%). The mortality from early studies that had small cohorts varied greatly and generally ranged from 9.5% to 26%. In the early 2000s, endovascular techniques for repairing AAAs started gaining favor, and by 2006, the number of EVAR procedures surpassed that of open procedures. 15 Clinical trials demonstrated that EVAR resulted in better perioperative mortality and morbidity, but long-term survival benefits were lost after 2 years of follow-up. 16 As EVAR became more widely accepted, single-center studies with small cohorts emerged to examine the use of EVAR to treat symptomatic AAAs. These studies had findings similar to ours; that is, shorter hospital stay, reduced blood loss, and a 0% to 5% mortality. 13, 14 Results of studies of open repair and EVAR for symptomatic AAA using large databases have been mixed. 8, 9 De Martino et al 7 identified 156 symptomatic patients using the Vascular Surgery Group of New England Vascular Quality Initiative database and did not find a significant difference in in-hospital mortality for patients who underwent open repair vs EVAR (2.1% vs 0%; P ¼ .26). However, their overall mortality rate was 1.3%, lower than our rate of 5.6%. This difference may be explained by differences in comorbidities, erroneous up-coding of aneurysms as symptomatic, or differences between in-hospital mortality available in Vascular Quality Initiative data and 30-day mortality as defined in our study. In-hospital mortality may underestimate the true perioperative mortality of a cohort, especially for patients receiving EVAR, who may have short hospital stays with an increased risk of death after discharge compared with open repairs. Another recent study using National Surgical Quality Improvement Program data did demonstrate an overall mortality of 5.1% for symptomatic patients, which is very similar to the overall mortality of 5.6% in our cohort. 9 Our study found patients were strikingly similar in demographics and comorbidities between eras. Although we did observe an increase in hyperlipidemia in era 2, we felt that this may have reflected an increased use of statins and, therefore, better documentation of hyperlipidemia rather than an actual rise in this medical problem. The significant reduction in the proportion of patients who had tender aneurysms in era 2 compared to era 1 was also an interesting finding. We believe that was more likely to have been a manifestation of a decreased emphasis on the physical examination in the modern era rather the result of a difference in pathophysiology of symptomatic aneurysms. The greater need for suprarenal clamping and trend toward increased blood loss in patients who underwent open repair in era 2 suggests that the operations may have been more complex because they likely represented patients with anatomic constraints that precluded an endovascular option. Increased EVAR experience and improved techniques to minimize the risk of contrast-induced nephropathy most likely explains our observed reduction in contrast volume and intraoperative blood loss for patients in era 2. We did not see a statistically significant difference in risk factors between eras, but there was a trend toward a lower threshold to operate on high-risk patients. This can be noted by the higher (although not statistically significant) perioperative mortality rate in era 2 for EVAR patients (3 [5%] vs 0). The three deaths in the era 2 EVAR group included a patient with a shaggy aorta who experienced acute kidney injury due to renal artery embolization, a patient with very severe dilated cardiomyopathy, and a patient who was ultimately found to have advanced gastric cancer, all patients who likely would not have been operated on in the primarily open era. Complication rates were similar between both eras, with a decrease in gastrointestinal complications and wound infections reflective of an increased use of EVAR in era 2. However perioperative mortality rates were higher in era 2 for EVAR patients compared with era 1 (3 vs 0).
Lastly, although perioperative mortality was similar between eras, the Kaplan-Meier survival analysis suggests an overall improvement in long-term survival for patients in era 2 after 3 years. This apparent survival benefit may reflect improved management of cardiovascular disease in the modern era.
At our institution, the current management of symptomatic AAA begins with radiographic evaluation for rupture, followed by medically optimizing the patient's hemodynamics. If the pain is ongoing after the vital signs are addressed, we tend to operate on the same day if possible. If the patient's symptoms improve with medical optimization, our tendency would be to operate at the next available time, which could be the next morning. Patients are generally monitored in the intensive care unit before repair. The choice between open or endovascular repair follows along the same lines as for elective AAA repairs, mainly determined by anatomic criteria, age, comorbidities, and patient preference.
Our study has certain limitations. Perioperative mortality event rates were low for the entire study period, which substantially limited our power to detect differences between the eras. Other limitations include those inherent to the retrospective study design as well as the single-institution source of the data, including the lack of adequate data for patient medications such as statin use and dosage. Given the difference in hyperlipidemia rates in era 2 compared with era 1, this particular information would have been useful but was not reliably available for all of our patients treated during the past 20 years.
Our analysis did not include data on patients who may have initially presented with a symptomatic AAA that ruptured during observation or repair. However, in a recent review of our ruptured aneurysm experience from 2005 to 2014, we found no patients whose AAA ruptured during observation. 17 A particular factor for this study was the lack of standardization in the management of symptomatic aneurysms because this study encompassed a 20-year period and several staff surgeons. The approach to patients depended on surgeon preference and clinical factors and could not be controlled. We believe, however, that our in-depth review of all records resulted in a true representation of symptomatic aneurysms treated during our study period, a diagnosis that is sometimes difficult to verify.
CONCLUSIONS
This is the first study evaluating the effect of the endovascular shift in the treatment of AAAs on the management and outcomes of patients with symptomatic AAA. Our study demonstrates that symptomatic AAAs remain their own entity, representing w10% to 11% of overall aneurysms. Similar to elective management, the modern approach to symptomatic AAAs has evolved to be primarily endovascular, and this is associated with shorter hospital lengths of stay and fewer gastrointestinal and wound complications but no significant difference in overall mortality. 
AUTHOR CONTRIBUTIONS

